Fish oil treatment shows promise for liver disease in kids on IV feeding
NCT ID NCT01194063
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a fish oil emulsion called Omegaven to treat liver disease in 36 children who depend on long-term intravenous (IV) nutrition. The goal was to lower bilirubin levels, a sign of liver damage. The treatment aims to control the disease and improve liver function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLESTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, 96826, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.